VEGF targets the tumour cell.
- Citation data:
Nature reviews. Cancer, ISSN: 1474-1768, Vol: 13, Issue: 12, Page: 871-82
- Publication Year:
- Repository URL:
- https://escholarship.umassmed.edu/cancerbiology_pp/218; https://works.bepress.com/arthur_mercurio/120
- Medicine; Biochemistry, Genetics and Molecular Biology; Animals; Antineoplastic Agents; Autocrine Communication; Capillary Permeability; Humans; Molecular Targeted Therapy; Neoplasms; Neoplastic Stem Cells; Neuropilins; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Cancer Biology; Neoplasms
- Most Recent Tweet View All Tweets
The function of vascular endothelial growth factor (VEGF) in cancer is not limited to angiogenesis and vascular permeability. VEGF-mediated signalling occurs in tumour cells, and this signalling contributes to key aspects of tumorigenesis, including the function of cancer stem cells and tumour initiation. In addition to VEGF receptor tyrosine kinases, the neuropilins are crucial for mediating the effects of VEGF on tumour cells, primarily because of their ability to regulate the function and the trafficking of growth factor receptors and integrins. This has important implications for our understanding of tumour biology and for the development of more effective therapeutic approaches.